| NCT ID | NCT03297034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bern |
| Condition | Childhood Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,136 participants |
| Start Date | 2007-01-01 |
| Primary Completion | 2050-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,136 participants in total. It began in 2007-01-01 with a primary completion date of 2050-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The SCCSS is designed to investigate which long-term effects childhood cancer and its treatment have on survivors, and includes those who were under 20 years when they were diagnosed. The SCCSS explores childhood cancer survivors' quality of life, the health care received by childhood cancer survivors during follow-up care, the effects of medication, somatic and psychosocial health issues, how childhood cancer survivors take care of their own health including health behaviors, and also collects demographic details like family background, education and profession. To learn more about these topics, the investigators send questionnaires to childhood or adolescent cancer survivors. The investigators use the results to inform physicians and patients, and to improve treatment of childhood cancer and follow-up.
Eligibility Criteria
Inclusion Criteria: * Who were diagnosed with cancer at age \<20 years * Who have survived at least 5 years after cancer diagnosis * Who were Swiss residents when they were diagnosed, and * Who gave informed consent
Contact & Investigator
Claudia E Kuehni, Prof.
STUDY DIRECTOR
Institute of Social and Preventive Medicine (ISPM), Univeristy of Bern
Frequently Asked Questions
Who can join the NCT03297034 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, studying Childhood Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03297034 currently recruiting?
Yes, NCT03297034 is actively recruiting participants. Contact the research team at claudia.kuehni@unibe.ch for enrollment information.
Where is the NCT03297034 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT03297034 clinical trial?
NCT03297034 is sponsored by University of Bern. The principal investigator is Claudia E Kuehni, Prof. at Institute of Social and Preventive Medicine (ISPM), Univeristy of Bern. The trial plans to enroll 4,136 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.